Symphony Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Symphony Asset Management's ELV Position: Q3 2018 in Review
Symphony Asset Management sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 4,609 shares — an estimated $1.01M sold.
Symphony Asset Management first reported a position in ELV in Q3 2013 and held it in 13 quarters. The position peaked at $11.6M in Q3 2013. 947 funds tracked by Wall St. Rank hold ELV as of Q3 2018.
- Symphony Asset Management reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
- Symphony Asset Management sold 4,609 Elevance Health shares in Q3 2018, an estimated $1.01M.
- Symphony Asset Management first reported a position in Elevance Health in Q3 2013 and held it in 13 quarters.
- Symphony Asset Management's Elevance Health position peaked at $11.6M in Q3 2013.
- 947 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.
Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.